Sandip Kapadia sold $68k of HRMY
CHIEF FINANCIAL OFFICER at Harmony Biosciences Holdings, Inc.. 1,775 shares at an average of $38.05, traded Jan 27, 2025, filed Jan 28, 2025.
Score components
- +22RoleCFO
- +8Trade size$68k at market
- +20Share of holdings soldSold 100% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-25-002158, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 24, 2025 | MOption exercise Common Stock10b5-1 | +3,812 | $0.00 | $0 | 3,812 | Jan 28, 2025 |
| Jan 24, 2025 | FTax withholding Common Stock10b5-1 | -2,037 | $38.01 | $77k | 1,775 | Jan 28, 2025 |
| Jan 27, 2025 | SOpen-market sale Common Stock10b5-1 | -1,775 | $38.05 | $68k | 0 | Jan 28, 2025 |
| Jan 24, 2025 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -3,812 | $0.00 | $0 | 11,438 | Jan 28, 2025 |
| Jan 25, 2025 | AGrant or award Stock Optionderivative10b5-1 | +66,250 | $0.00 | $0 | 66,250 | Jan 28, 2025 |
| Jan 25, 2025 | AGrant or award Restricted Stock Unitsderivative10b5-1 | +18,900 | $0.00 | $0 | 18,900 | Jan 28, 2025 |
Related signals
Other insiders at Harmony Biosciences Holdings, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | Harmony Biosciences Holdings, Inc. | Kumar Budur CHIEF MEDICAL OFFICER | $1.7M 38,452 shares | -258% | |
| 25Weak | Harmony Biosciences Holdings, Inc. | Kumar Budur CHIEF MEDICAL OFFICER | $1.5M 33,954 shares | -141% | |
| 18Weak | Harmony Biosciences Holdings, Inc. | Sandip Kapadia CHIEF FINANCIAL OFFICER | $139k 3,746 shares | -13% | |
| 44Moderate | Harmony Biosciences Holdings, Inc. | Sandip Kapadia CHIEF FINANCIAL OFFICER | $753k 20,961 shares | -100% | |
| 43Moderate | Harmony Biosciences Holdings, Inc. | Jeffrey M. Dayno PRESIDENT, CEO | $1.0M 25,933 shares | -130% | |
| 37Weak | Harmony Biosciences Holdings, Inc. | Sandip Kapadia CHIEF FINANCIAL OFFICER | $791k 20,000 shares | -100% | |
| 32Weak | Harmony Biosciences Holdings, Inc. | Sandip Kapadia CHIEF FINANCIAL OFFICER | $120k 3,427 shares | -100% | |
| 44Moderate | Harmony Biosciences Holdings, Inc. | Sandip Kapadia CHIEF FINANCIAL OFFICER | $787k 21,573 shares | -100% | |
| 35Weak | Harmony Biosciences Holdings, Inc. | Sandip Kapadia CHIEF FINANCIAL OFFICER | $227k 6,987 shares | -100% | |
| 11Weak | Harmony Biosciences Holdings, Inc. | Jeffrey Dierks CHIEF COMMERCIAL OFFICER | $159k 4,869 shares | -100% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.